Events
3 – 10 MAY 2023
Congress Integrative Medicine
“Medicine at the turn of the times”
Integrative medicine, natural and cultural medicine bear a great responsibility in the
turn of the times.
All information about the exciting 2023 programme on the beautiful island of Kos can be found here:
http://kos-kongress.de.
As always, the congress will take place at Hotel Neptune Resorts. Information
about the hotel can be found on the website: www.neptune.gr.
The MYCB1 team is looking forward to seeing you there!
30 OCTOBER 2022
25TH SOUTHWEST GERMAN PAIN
Dr. Heinrish Binsfeld is giving a 40″ lecture on his experience with MYCB1 + ALETTA at the 25th Southwest German Pain Days Conference, on the 30th of October in the city of Goeppingen, organized by German Society for Pain Medicine e. V For 25 years, the Southwest German Pain Days have shown new developments in pain medicine, this event is intended to show where modern basic research and clinical research are leading the pain medicine of the future. (Dr. Heinrich Binsfeld, is Vice President of the German Society for Pain Medicine)
3 JUNE 2022
PREMIERE: THE DOCTOR – FRANJO GROTENHERMEN
MYCB1 has produced an award winning documentary in 12 countries: The Doctor – Franjo Grotenhermen, about the life of a pioneering physician in Germany who was the first in the healthcare sector to foster the therapeutic potential of medicinal cannabis in Europe. Premiere: 3rd of June, 2022, 19:30 at Lab 111 cinema in Amsterdam. For more information, tickets for the premiere in Amsterdam, and online reservations for the Metaverse release, please see MYCB1.TV
This is the first of a Documentary Series by MYCB1 aimed at inspiring and improving humanity by supporting exceptional individuals and institutions who push the boundaries of science, art, music and other forms of creativity.
The documentary was also reviewed extensively in Dutch news paper “Het Parool“.
25 MAY 2022
DATA-DRIVEN HEALTHCARE CONFERENCE
MYCB1 + ALETTA will be presented at the Dutch Data-Driven Healthcare Conference by the CEO, Ernesto Diringuer. During the conference on 25 May 2022, electronic data exchange in healthcare, personalized care pathways and networked care will be discussed in detail. The Dutch Ministry of Health, Welfare and Sport support the initiative.
We look forward to seeing you there. Visit the website for more information.
19 – 20 MAY 2022
PAIN SCIENCE IN MOTION IIV
MYCB1 + ALETTA research methodology will be presented at a conference Pain in Motion organized by the Pain in Motion international research group, the department of Rehabilitation Medicine, Research School of CAPHRI, Maastricht University, and the Center of Expertise in Rehabilitation and Pain Adelante/MUMC+.
We look forward to seeing you there. Please register here.
19 MAY 2022
KNMP – PRISMA Symposium 2022: Real World Evidence
The upcoming PRISMA symposium will take place on Thursday 19 May 2022. The symposium is accredited with 5 hours for community pharmacists and hospital pharmacists. In the parallel sessions, researchers can share their latest insights for pharmaceutical practice.
Ernesto Diringuer, CEO of MYCB1 will present a retrospective observational study with the outcomes of ALETTA 1.0 in a real world setting of a patient with chronic pain under cannabinoid-based treatment
21 APRIL 2022
INNOVATION FOR HEALTH
A poster presentation of research findings on MYCB1 products + ALETTA will be presented at the 9th edition of the Innovation for Health conference, a leading conference for key players in Health & Life Sciences in The Netherlands.
We look forward to seeing you there. Please register here.
9 OCT. 2021
Amsterdam Impact by City of Amsterdam
MYCB1 being an example of corporate responsibility at “Amsterdam Impact”, an initiative by the City of Amsterdam. Amsterdam has become a global frontrunner in the impact economy. The Amsterdam Impact programme is in place to strengthen the ecosystem for all companies, large and small, that create both financial and social value.
For more information click here.